200 related articles for article (PubMed ID: 18241016)
1. Roles of thromboxane A2 and 5-hydroxytryptamine in endotoxin-induced digital vasoconstriction in horses.
Menzies-Gow NJ; Sepulveda MF; Bailey SR; Cunningham FM; Elliott J
Am J Vet Res; 2008 Feb; 69(2):199-207. PubMed ID: 18241016
[TBL] [Abstract][Full Text] [Related]
2. Endotoxaemia in rats: role of NO, PAF and TXA2 in pulmonary neutrophil sequestration and hyperlactataemia.
Olszanecki R; Chłopicki S
J Physiol Pharmacol; 1999 Sep; 50(3):443-54. PubMed ID: 10574473
[TBL] [Abstract][Full Text] [Related]
3. Equine peritoneal macrophage production of thromboxane and prostacyclin in response to platelet activating factor and its receptor antagonist SRI 63-441.
Morris DD; Moore JN
Circ Shock; 1989 Jun; 28(2):149-58. PubMed ID: 2544315
[TBL] [Abstract][Full Text] [Related]
4. Role of thromboxane A2 and platelet activating factor in early haemodynamic response to lipopolysaccharide in rats.
Bocheński J; Chłopicki S; Gryglewski RJ
J Physiol Pharmacol; 1999 Jun; 50(2):287-97. PubMed ID: 10424723
[TBL] [Abstract][Full Text] [Related]
5. Endotoxin-induced digital vasoconstriction in horses: associated changes in plasma concentrations of vasoconstrictor mediators.
Menzies-Gow NJ; Bailey SR; Katz LM; Marr CM; Elliott J
Equine Vet J; 2004 Apr; 36(3):273-8. PubMed ID: 15147137
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the induction of vasoactive mediators from equine digital vein endothelial cells by endotoxin.
Menzies-Gow NJ; Bailey SR; Berhane Y; Brooks AC; Elliott J
Am J Vet Res; 2008 Mar; 69(3):349-55. PubMed ID: 18312133
[TBL] [Abstract][Full Text] [Related]
7. Plasma concentrations of endotoxin and platelet activation in the developmental stage of oligofructose-induced laminitis.
Bailey SR; Adair HS; Reinemeyer CR; Morgan SJ; Brooks AC; Longhofer SL; Elliott J
Vet Immunol Immunopathol; 2009 Jun; 129(3-4):167-73. PubMed ID: 19091426
[TBL] [Abstract][Full Text] [Related]
8. Involvement of platelet activating factor in immediate heart response to lipopolysaccharide.
Jakubowski A; Olszanecki R; Chlopicki S
J Physiol Pharmacol; 2004 Jun; 55(2):409-21. PubMed ID: 15213362
[TBL] [Abstract][Full Text] [Related]
9. Role of platelet activating factor in development of thrombocytopenia and neutropenia in dogs with endotoxemia.
Tsuchiya R; Kyotani K; Scott MA; Nishizono K; Ashida Y; Mochizuki T; Kitao S; Yamada T; Kobayashi K
Am J Vet Res; 1999 Feb; 60(2):216-21. PubMed ID: 10048555
[TBL] [Abstract][Full Text] [Related]
10. Endotoxin-induced activation of equine platelets: evidence for direct activation of p38 MAPK pathways and vasoactive mediator production.
Brooks AC; Menzies-Gow NJ; Wheeler-Jones C; Bailey SR; Cunningham FM; Elliott J
Inflamm Res; 2007 Apr; 56(4):154-61. PubMed ID: 17522813
[TBL] [Abstract][Full Text] [Related]
11. Interactions of constitutive nitric oxide with PAF and thromboxane on rat intestinal vascular integrity in acute endotoxaemia.
László F; Whittle BJ; Moncada S
Br J Pharmacol; 1994 Dec; 113(4):1131-6. PubMed ID: 7889265
[TBL] [Abstract][Full Text] [Related]
12. Failure of aspirin to impair bovine platelet function.
Gentry PA; Tremblay RR; Ross ML
Am J Vet Res; 1989 Jun; 50(6):919-22. PubMed ID: 2764343
[TBL] [Abstract][Full Text] [Related]
13. Platelet-activating factor and not thromboxane A2 is an important mediator of endotoxin-induced platelet aggregation in equine heparinised whole blood in vitro.
Jarvis GE; Evans RJ
Blood Coagul Fibrinolysis; 1996 Mar; 7(2):194-8. PubMed ID: 8735817
[TBL] [Abstract][Full Text] [Related]
14. Endotoxin and dietary amines may increase plasma 5-hydroxytryptamine in the horse.
Bailey SR; Cunningham FM; Elliott J
Equine Vet J; 2000 Nov; 32(6):497-504. PubMed ID: 11093623
[TBL] [Abstract][Full Text] [Related]
15. Effects of tumor necrosis factor blockade on interleukin 6, lactate, thromboxane, and prostacyclin responses in miniature horses given endotoxin.
Cargile JL; MacKay RJ; Dankert JR; Skelley L
Am J Vet Res; 1995 Nov; 56(11):1445-50. PubMed ID: 8585654
[TBL] [Abstract][Full Text] [Related]
16. The involvement of adhesion molecules and lipid mediators in the adhesion of human platelets to eosinophils.
Jawień J; Lomnicka M; Korbut R; Chłopicki S
J Physiol Pharmacol; 2005 Dec; 56(4):637-48. PubMed ID: 16391420
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary and neutrophil responses to priming effects of platelet-activating factor in pigs.
Kruse-Elliott KT
Am J Vet Res; 1997 Dec; 58(12):1386-91. PubMed ID: 9401686
[TBL] [Abstract][Full Text] [Related]
18. Hypoxic pulmonary vasoconstriction in isolated blood-perfused rat lung; modulation by thromboxane A2, platelet-activating factor, cysteinyl leukotrienes and endothelin-1.
Chłopicki S; Bartuś JB; Gryglewski RJ
Pol J Pharmacol; 2002; 54(5):433-41. PubMed ID: 12593530
[TBL] [Abstract][Full Text] [Related]
19. The role of thromboxane A2 in endotoxin-induced aggregation of guinea-pig platelets in vitro.
Bult H; Herman AG
Agents Actions Suppl; 1979; (4):147-55. PubMed ID: 386740
[TBL] [Abstract][Full Text] [Related]
20. Opposite effects of WEB2086 on angiogenesis in atheromas and ischemic hindlimb of apoE gene deficient mice.
Wang S; Tang YL; Yang YZ; Xu ZX; Peng K
Chin Med J (Engl); 2007 May; 120(10):886-92. PubMed ID: 17543178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
